Calithera Biosciences CALA Stock
0.0001 USD
{{ price }}
-80.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
OTC Markets EXMKT
Market Cap
487 USD
LOW - HIGH [24H]
0.0001
-
0.0001 USD
VOLUME [24H]
200 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.32 USD
Calithera Biosciences Price Chart
Calithera Biosciences CALA Financial and Trading Overview
| Calithera Biosciences stock price | 0.0001 USD |
| Previous Close | 0.35 USD |
| Open | 0.35 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.35 - 0.35 USD |
| 52 Week Range | 0.01 - 5.1 USD |
| Volume | 8.47K USD |
| Avg. Volume | 43.26K USD |
| Market Cap | 1.71M USD |
| Beta (5Y Monthly) | 0.552816 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.32 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5 USD |
CALA Valuation Measures
| Enterprise Value | 262.37K USD |
| Trailing P/E | N/A |
| Forward P/E | -0.25925925 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.006 |
Trading Information
Calithera Biosciences Stock Price History
| Beta (5Y Monthly) | 0.552816 |
| 52-Week Change | -87.037% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.1 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.16 USD |
| 200-Day Moving Average | 1.22 USD |
CALA Share Statistics
| Avg. Volume (3 month) | 43.26K USD |
| Avg. Daily Volume (10-Days) | 47.36K USD |
| Shares Outstanding | 4.87M |
| Float | 4.76M |
| Short Ratio | 0.78 |
| % Held by Insiders | 1.07% |
| % Held by Institutions | 26.76% |
| Shares Short | 417.28K |
| Short % of Float | 8.91% |
| Short % of Shares Outstanding | 8.57% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -56.28% |
| Return on Equity (ttm) | -114.14% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -41819000 USD |
| Net Income Avi to Common (ttm) | -21290000 USD |
| Diluted EPS (ttm) | -7.94 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 25.45M USD |
| Total Cash Per Share (mrq) | 5.22 USD |
| Total Debt (mrq) | 1.67M USD |
| Total Debt/Equity (mrq) | 8.17 USD |
| Current Ratio (mrq) | 3.603 |
| Book Value Per Share (mrq) | -0.401 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -43608000 USD |
| Levered Free Cash Flow (ttm) | -28174250 USD |
Profile of Calithera Biosciences
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 343 Oyster Point Boulevard |
| ZIP | 94080 |
| Phone | (650) 870-1000 |
| Website | https://www.calithera.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Q&A For Calithera Biosciences Stock
What is a current CALA stock price?
Calithera Biosciences CALA stock price today per share is 0.0001 USD.
How to purchase Calithera Biosciences stock?
You can buy CALA shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Calithera Biosciences?
The stock symbol or ticker of Calithera Biosciences is CALA.
Which industry does the Calithera Biosciences company belong to?
The Calithera Biosciences industry is Biotechnology.
How many shares does Calithera Biosciences have in circulation?
The max supply of Calithera Biosciences shares is 4.87M.
What is Calithera Biosciences Price to Earnings Ratio (PE Ratio)?
Calithera Biosciences PE Ratio is now.
What was Calithera Biosciences earnings per share over the trailing 12 months (TTM)?
Calithera Biosciences EPS is -1.32 USD over the trailing 12 months.
Which sector does the Calithera Biosciences company belong to?
The Calithera Biosciences sector is Healthcare.
Calithera Biosciences CALA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
| NASDAQ Composite Total Return I XCMP | 20257.83 USD — |
-5.96
|
— — | 20236.33 USD — | 20672.41 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8098.63 USD — |
-5.98
|
— — | 8089.65 USD — | 8265.47 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}